About Cordis
Cordis is a Healthcare company based in Fremont (United States) founded in 1957, and was acquired by Hellman & Friedman in March 2021. Cardiovascular and endovascular devices are developed and marketed by Cordis. The company has 14 employees. Cordis has completed 3 acquisitions, including Flexible Stenting Solutions, Lumend and MedAlliance. Its chief executive, as recorded, is Shar Matin. Its website cordis.com draws about 44 thousand monthly visits. Its Indian entity Cordis India Medical Devices Private Limited reported revenue of ₹126 Cr. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation; 3 of its 3 listed competitors have raised funding.
Company details
Cordis was founded in 1957 and is headquartered in Fremont, United States. Operations focus on the medical device sector, where products including stents, catheters, guidewires, and vena cava filters are manufactured. These items support interventional medicine, minimally invasive imaging, and electrophysiology procedures. Distribution occurs globally through established channels in the cardiovascular field.
- Headquarters Fremont, United States
- Employees 14
- Stage Acquired
- SectorsHealthcare
- Website cordis.com
- Social LinkedIn
- Acquired by Hellman & Friedman (Mar 2021)
- Legal Name Cordis India Medical Devices Private Limited
- Date of Incorporation 29 Mar, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹126 Cr
FY 2025 · +31% YoY
- Indian entity net loss-₹9.68 Cr
FY 2025 · -8% margin
- Indian entity EBITDA-₹5.17 Cr
FY 2025 · -4% margin
- InvestorsKKR
& 3 more
- Employee Count14
- Investments & AcquisitionsFlexible Stenting Solutions
& 2 more
- Acquired by
Associated legal entities of Cordis
Cordis operates through Cordis India Medical Devices Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cordis India Medical Devices Private Limited CIN U51909MH2017FTC293184 | Active | 29 Mar 2017 | Mumbai, Maharashtra | ₹126 Cr | 14 | 4 | View details |
Investors in Cordis
Cordis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include KKR, Cardinal Health and Ajax Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multiple sectors are invested in by this private equity firm. | 1976 | kkr.com | New York, United States | |
Private equity firm focused on acquisitions | hf.com | San Francisco, United States | ||
Multiple healthcare products and services are provided to organizations. | 1971 | cardinalhealth.com | Dublin, United States | |
Health services are provided from California since 2016. | 2016 | ajaxhealth.com | California City, United States |
Investor details for Cordis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cordis India Medical Devices Private Limited (Cordis)
Cordis India Medical Devices Private Limited is the primary company behind Cordis. The board of Cordis India Medical Devices Private Limited currently have 3 directors; the longest-serving is Chetan Pravin Joshi, appointed in 2021. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Chetan Pravin Joshi DIN 09177711 | Director | 18 May 2021 | 5 yrs 5 mo | Cordis India Medical Devices Private Limited |
| Mahesh Joshi DIN 09832978 | Director | 31 Jan 2023 | 3 yrs 8 mo | Cordis India Medical Devices Private Limited |
| Kriti Khanna DIN 10790233 | Director | 27 Sep 2024 | 2 yrs 1 mo | Cordis India Medical Devices Private Limited |
People of Cordis
92 people are tracked at Cordis (46 in leadership, 46 in team); the tracked headcount is 14.
| Name | Role | Group |
|---|---|---|
Shar Matin | CEO | Leadership |
Ante Pavlovic | CEO & Director | Leadership |
Greg Schiffenhaus | Chief Of Staff To CEO | Leadership |
Nancy Pounder | Chief Human Resources Officer | Leadership |
Rob Beverly | Vice President Of Commercial, Us, Canada, Latin America And Puerto Rico | Leadership |
Pieter Dewandeleer | Senior Director, Head Of Finance International | Leadership |
Derek Craig | Vice President Operations | Leadership |
Scott Drake | Chief Executive Officer | Leadership |
George Adams | Chief Medical Officer | Leadership |
Zachary Rymer | Director Of Accounting, Assistant Controller | Leadership |
Nusrath Sultana | Head Of Clinical And Medical Affairs | Leadership |
Matthew Linville | Sr. Director, HR | Leadership |
Michelle Jin | Head Of Hr, APAC | Leadership |
Alexandra Smith | Director - Finance, Innovation And M&a | Leadership |
Nick Getter | Head Of Shared Services And Finance Transformation | Leadership |
Axel Girod | Director EMEA Supply Chain | Leadership |
Dave Bermudez | Director Of Operations | Leadership |
Dennis Whalen | Area Vice President, East | Leadership |
John Georges | VP Tax & Treasury | Leadership |
Courtney Bell | Head Of Global Talent Acquisition And Talent Development | Leadership |
72 more people are available in the full profile.
Complete people profiles for Cordis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cordis
Figures of Cordis India Medical Devices Private Limited, the primary company behind Cordis, for FY 2025. Revenue was ₹126 Cr (+31% year on year). Net loss was -₹9.68 Cr (-8% margin). EBITDA was -₹5.17 Cr (-4% margin). Revenue has grown at a compounded annual rate of +8% over three years and +9% over five years.
- ₹126 CrRevenue · FY 2025 · +31% YoY
- -₹9.68 CrNet loss · -8% margin
- -₹5.17 CrEBITDA · -4% margin
- ₹49.05 CrPaid-up capital
- 14Employees (provident fund records)
- +8%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cordis India Medical Devices Private Limited are on its company page.
Detailed financial statements for Cordis
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cordis
Cordis has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Flexible Stenting Solutions, Lumend and MedAlliance.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of drug delivery device for the treatment of coronary and peripheral artery diseases | medalliance.com | Nyon, Switzerland | 2008 | Oct 2023 | $1.14B | |
Self-expanding biliary stents are developed for palliative treatment of strictures. | flexiblestent.com | Eatontown, United States | 2006 | Mar 2013 | •••• | |
Catheter-based technologies for crossing chronic vascular occlusions are developed. | lumend.com | Redwood, United States | 1996 | Sep 2005 | •••• |
Complete acquisition details for Cordis
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cordis
6 dated milestones of Cordis across 66 years, from founding to its latest funding, stage changes and deals.
- Founded Cordis is founded.
- Acquisition Acquires Lumend.
- Acquisition Acquires Flexible Stenting Solutions.
- Exit Acquired by Cardinal Health.
- Exit Acquired by Hellman & Friedman.
- Acquisition Acquires MedAlliance.
Competitors of Cordis
Cordis has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Aziyo Biologics and EKOS Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. |
Detailed competitors of Cordis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cordis
The website of Cordis (cordis.com) receives about 44.3K visits a month.
- Monthly visits44.3K
▼ 7.1% vs previous month
Websites whose visitors overlap most with Cordis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bostonscientific.com | 100% | 738.5K | #88,615 | View details | |
| medtronic.com | 92% | 2.6M | #22,622 | View details | |
| dicardiology.com | 86% | 79.8K | #510,652 | View details | |
medcompnet.com | medcompnet.com | 84% | – | ||
| biosensewebster.com | 84% | 1.9K | #8,363,106 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 37 similar websites and full traffic analytics for Cordis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 37 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Medical Equipment & Supplies
3 companies that operate in the same segment as Cordis (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Robotic waterjet system for prostate tissue removal is developed. | 2009 | Redwood City, California, United States | USD 348.84 M | USD 308.05 M | 756 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 | ||
Injectable packaging, containment, and delivery solutions are manufactured. | 1923 | Exton, Pennsylvania, United States | USD 3.07 B | 10,600 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cordis
Complete news archive for Cordis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cordis
Cordis was founded in 1957.
Cordis is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Shar Matin is the CEO of Cordis, as recorded in our data.
Cordis has 14 employees.
The primary company behind Cordis, Cordis India Medical Devices Private Limited, reported revenue of ₹126 Cr for FY 2025, up 31% year on year.
Cordis was founded in 1957 and is headquartered in Fremont, United States. Operations focus on the medical device sector, where products including stents, catheters, guidewires, and vena cava filters are manufactured. These items support interventional medicine, minimally invasive imaging, and electrophysiology procedures. Distribution occurs globally through established channels in the cardiovascular field.
Cordis's top competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation.
Cordis has made 3 acquisitions, including Flexible Stenting Solutions, Lumend, and MedAlliance.
Cordis has 4 investors. Key investors include KKR, Cardinal Health, Ajax Health, and Hellman & Friedman.
Cordis operates through Cordis India Medical Devices Private Limited.
Yes. Cordis was acquired by Hellman & Friedman in March 2021.
The legal entities of Cordis currently have 4 directors, including Chetan Pravin Joshi, Mahesh Joshi, Kriti Khanna and others.